Advances in cutaneous squamous cell carcinoma

This Review outlines risk factors and prevention strategies for cutaneous squamous cell carcinoma (cSCC) and highlights recent advances in the understanding of the impact of molecular and cellular intra-tumour heterogeneity that provide the basis for new therapeutic strategies to treat advanced cSCC. Human malignancies arise predominantly in tissues of epithelial origin, where the stepwise transformation from healthy epithelium to premalignant dysplasia to invasive neoplasia involves sequential dysregulation of biological networks that govern essential functions of epithelial homeostasis. Cutaneous squamous cell carcinoma (cSCC) is a prototype epithelial malignancy, often with a high tumour mutational burden. A plethora of risk genes, dominated by UV-induced sun damage, drive disease progression in conjunction with stromal interactions and local immunomodulation, enabling continuous tumour growth. Recent studies have identified subpopulations of SCC cells that specifically interact with the tumour microenvironment. These advances, along with increased knowledge of the impact of germline genetics and somatic mutations on cSCC development, have led to a greater appreciation of the complexity of skin cancer pathogenesis and have enabled progress in neoadjuvant immunotherapy, which has improved pathological complete response rates. Although measures for the prevention and therapeutic management of cSCC are associated with clinical benefit, the prognosis remains poor for advanced disease. Elucidating how the genetic mechanisms that drive cSCC interact with the tumour microenvironment is a current focus in efforts to understand, prevent and treat cSCC.

Automated summary

This Review provides an overview of risk factors and prevention strategies for cSCC, and highlights recent advances in understanding the impact of molecular and cellular intra-tumour heterogeneity in new therapeutic strategies. Despite clinical benefits associated with prevention and therapeutic management, the prognosis for advanced cSCC remains poor. Understanding the interaction between genetic mechanisms driving cSCC and the tumour microenvironment is a current focus in cSCC research.